Your browser doesn't support javascript.
loading
Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia.
Dyal, Jonathan; Kofman, Aaron; Kollie, Jomah Z; Fankhauser, John; Orone, Romeo; Soka, Moses J; Glaybo, Uriah; Kiawu, Armah; Freeman, Edna; Giah, Giovanni; Tony, Henry D; Faikai, Mylene; Jawara, Mary; Kamara, Kuku; Kamara, Samuel; Flowers, Benjamin; Kromah, Mohammed L; Desamu-Thorpe, Rodel; Graziano, James; Brown, Shelley; Morales-Betoulle, Maria E; Cannon, Deborah L; Su, Kaihong; Linderman, Susanne L; Plucinski, Mateusz; Rogier, Eric; Bradbury, Richard S; Secor, W Evan; Bowden, Katherine E; Phillips, Christi; Carrington, Mary N; Park, Yeon-Hwa; Martin, Maureen P; Aguinaga, Maria Del Pilar; Mushi, Robert; Haberling, Dana L; Ervin, Elizabeth D; Klena, John D; Massaquoi, Moses; Nyenswah, Tolbert; Nichol, Stuart T; Chiriboga, David E; Williams, Desmond E; Hinrichs, Steven H; Ahmed, Rafi; Vonhm, Benjamin T; Rollin, Pierre E; Purpura, Lawrence J; Choi, Mary J.
Afiliación
  • Dyal J; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Kofman A; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Kollie JZ; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Fankhauser J; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Orone R; Men's Health Screening Program, Monrovia, Liberia.
  • Soka MJ; ELWA Hospital, Samaritan's Purse, Monrovia, Liberia.
  • Glaybo U; ELWA Hospital, Samaritan's Purse, Monrovia, Liberia.
  • Kiawu A; ELWA Hospital, Samaritan's Purse, Monrovia, Liberia.
  • Freeman E; Men's Health Screening Program, Monrovia, Liberia.
  • Giah G; Men's Health Screening Program, Monrovia, Liberia.
  • Tony HD; Men's Health Screening Program, Monrovia, Liberia.
  • Faikai M; Men's Health Screening Program, Monrovia, Liberia.
  • Jawara M; Men's Health Screening Program, Monrovia, Liberia.
  • Kamara K; Men's Health Screening Program, Monrovia, Liberia.
  • Kamara S; Men's Health Screening Program, Monrovia, Liberia.
  • Flowers B; Men's Health Screening Program, Monrovia, Liberia.
  • Kromah ML; Men's Health Screening Program, Monrovia, Liberia.
  • Desamu-Thorpe R; Men's Health Screening Program, Monrovia, Liberia.
  • Graziano J; Men's Health Screening Program, Monrovia, Liberia.
  • Brown S; Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Morales-Betoulle ME; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Cannon DL; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Su K; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Linderman SL; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Plucinski M; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Rogier E; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.
  • Bradbury RS; Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Secor WE; Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Bowden KE; Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Phillips C; Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Carrington MN; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Park YH; Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Martin MP; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
  • Aguinaga MDP; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Mushi R; Ragon Institute of MGH, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, USA.
  • Haberling DL; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
  • Ervin ED; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.
  • Klena JD; Department of Internal Medicine, Meharry Sickle Cell Center, Meharry Medical College, Nashville, Tennessee, USA.
  • Massaquoi M; Department of Obstetrics and Gynecology, Meharry Sickle Cell Center, Nashville, Tennessee, USA.
  • Nyenswah T; Department of Internal Medicine, Meharry Sickle Cell Center, Meharry Medical College, Nashville, Tennessee, USA.
  • Nichol ST; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Chiriboga DE; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Williams DE; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Hinrichs SH; Ministry of Health, Liberia.
  • Ahmed R; Ministry of Health, Liberia.
  • Vonhm BT; Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Rollin PE; University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Purpura LJ; Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Choi MJ; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Clin Infect Dis ; 76(3): e849-e856, 2023 02 08.
Article en En | MEDLINE | ID: mdl-35639875
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans / Male País/Región como asunto: Africa Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans / Male País/Región como asunto: Africa Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos